Lyra Therapeutics (LYRA) Announces Appointment of Robert Kern, MD, as Chief Medical Officer

Go back to Lyra Therapeutics (LYRA) Announces Appointment of Robert Kern, MD, as Chief Medical Officer

Lyra Therapeutics Announces Appointment of Robert Kern, MD, as Chief Medical Officer

February 17, 2021 8:00 AM EST

Thought leader in the ENT treatment community brings insight from clinical practice to next stage of development for LYR-210 and pipeline

WATERTOWN, Mass.--(BUSINESS WIRE)-- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and... More